Additionally, well-known predictors of outcome such as tumor characteristics (size and number) and alpha-fetoprotein (AFP) were evaluated to provide a more comprehensive assessment of this population, with the ultimate goal of enhancing treatment selection and patient prognostication. This evidence concerns the gene AFP and neoplasm.